These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series. Dell'Osso B; Mundo E; Altamura AC CNS Spectr; 2006 Nov; 11(11):879-83; quiz 885. PubMed ID: 17075559 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610 [TBL] [Abstract][Full Text] [Related]
9. Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder. Fontenelle LF; Mendlowicz MV; Miguel EC; Versiani M World J Biol Psychiatry; 2005; 6(1):57-9. PubMed ID: 16097406 [TBL] [Abstract][Full Text] [Related]
10. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia. Dwivedi S; Pavuluri M; Heidenreich J; Wright T J Child Adolesc Psychopharmacol; 2002; 12(1):69-70. PubMed ID: 12014598 [No Abstract] [Full Text] [Related]
11. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. Francobandiera G Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793 [TBL] [Abstract][Full Text] [Related]
12. Quetiapine augmentation of sertraline in obsessive-compulsive disorder. Francobandiera G J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688 [No Abstract] [Full Text] [Related]
16. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614 [TBL] [Abstract][Full Text] [Related]
17. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases. Sun TF; Lin PY; Wu CK Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630 [TBL] [Abstract][Full Text] [Related]
18. The promise of N-acetylcysteine in the treatment of obsessive-compulsive disorder. Carollo M; Carollo N; Montan G CNS Neurosci Ther; 2024 Feb; 30(2):e14653. PubMed ID: 38385640 [No Abstract] [Full Text] [Related]
19. Vortioxetine and Aripiprazole Combination in Treatment-Resistant Obsessive-Compulsive Disorder: A Case Report. De Berardis D; Olivieri L; Nappi F; Rapini G; Vellante F; Matarazzo I; Serroni N; Di Giannantonio M J Clin Psychopharmacol; 2017 Dec; 37(6):732-734. PubMed ID: 29040153 [No Abstract] [Full Text] [Related]
20. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder. Mohr N; Vythilingum B; Emsley RA; Stein DJ Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]